@rautoupe.bsky.social
📤 51
📥 43
📝 6
reposted by
Wilco Kwanten
6 months ago
In the (early) pathophysiology of MASLD the LSEC and microvascular alterations are key. Lanifibranor improves LSEC capillarisation and dysfunction!
tinyurl.com/x37637j4
#AntwerpHepatology
#AntwerpHypothesis
@rautoupe.bsky.social
@svenfrancque.bsky.social
0
4
3
reposted by
DECISION Horizon2020
6 months ago
Is the etiological work-up of
#PSVD
a one-size-fits-all? DECISION consortium member Lucile Moga from APHP takes part in EASL/ VALDIG's session on "Do's and Don'ts in the management of Porto-Sinusoidal Vascular Disease".
#EASLCongress
#EASL2025
#LiverResearch
@easlnews.bsky.social
loading . . .
0
7
1
reposted by
6 months ago
📢 First
@easlnews.bsky.social
CPG on surgery in cirrhosis presented today together with the one on TIPS! 🤝 See you at 10:30 Erlinger Room!
@bavenocoop.bsky.social
#LiverSky
add a skeleton here at some point
0
5
4
reposted by
DECISION Horizon2020
6 months ago
Estefania Huergo presents methylation data in AD patients, selected as best Young Investigator abstract in Basic Science at
#EASL2025
- Congrats! 🎉
@navarrabiomed.bsky.social
@easlnews.bsky.social
#Epigenetics
#LiverResearch
loading . . .
0
9
3
reposted by
DECISION Horizon2020
6 months ago
Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk.
@rwth.bsky.social
@brunslab.bsky.social
@easlnews.bsky.social
#Cirrhosis
#ACLF
#EASL2025
"
loading . . .
0
9
5
reposted by
DECISION Horizon2020
6 months ago
❤️ Cardiac performance is impaired in patients with proven alcohol-related hepatitis and predicts 3-month mortality in this patient population
#POSTER
SAT-503-YI by Pierre-Emmanuel Rautou (
@inserm.fr
, APHP, EF CLIF) 📅 Presented at the
#EASLCongress
|
#EASL2025
@easlnews.bsky.social
0
9
5
reposted by
DECISION Horizon2020
6 months ago
How do you build&lead a successful research team? The next generation of PIs learned straight from the best in today's workshop “How to Start a Research Group: From Postdoc to PI" as
@rautoupe.bsky.social
shared practical insights on building&maintaining a high-performing team.
@inserm.fr
#EASL2025
loading . . .
0
8
3
reposted by
DECISION Horizon2020
6 months ago
Greetings from the DECISION Investigator Meeting at
#EASL2025
: Study updates and collaborative discussions with Paolo Caraceni &
@rautoupe.bsky.social
#ClinicalTrials
#cirrhosis
loading . . .
0
5
2
reposted by
DECISION Horizon2020
6 months ago
Good morning! DECISION coordinator Pierre-Emmanuel Rautou just started the early morning abstract session on
#cirrhosis
at the
#EASLCongress
in Amsterdam. You can still join in the Benhamou Room until 09.45am!
@easlnews.bsky.social
0
7
3
reposted by
DECISION Horizon2020
6 months ago
Next at the DECISION Networking Session at
#EASL2025
, Theresa Wirtz (UKA) presents scRNA-seq data showing a monocyte subset linked to ACLF risk. Fascinating translational science in action!
@brunslab.bsky.social
ky.social
@easlnews.bsky.social
ky.social
#scRNAseq
#ACLF
loading . . .
0
11
7
reposted by
DECISION Horizon2020
6 months ago
Lastly at DECISION's Networking Session, Richard Moreau shares new data: high-throughput omics reveals biomarkers for infection & poor outcomes in cirrhosis.
@inserm.fr
@easlnews.bsky.social
sky.social
#Metabolomics
#Cytokinomics
#EASL2025
loading . . .
0
7
3
reposted by
📢📢 looking for a co-founder (CEO) for an early stage medtech startup‼️ Our goal: bring extracellular vesicles from the lab to the bedside of patients with chronic liver disease.🧪 Find the offer here:
www.lesdeeptech.fr/tandem/41693...
8 months ago
0
2
1
reposted by
DECISION Horizon2020
6 months ago
Kicking off our
#EASL2025
Networking Session with an intro to the DECISION project by coordinator Pierre-Emmanuel Rautou - Let’s talk systems medicine, cirrhosis, and precision care!
@rautoupe.bsky.social
pe.bsky.social
@easlnews.bsky.social
ky.social
#LiverDisease
0
9
4
Interested in vascular liver diseases and more broadly in liver and vessels? ▶️Join the COST Action EURO-VALDI-NET:
www.cost.eu/actions/CA23...
Eligibility criteria there:
www.cost.eu/am-i-eligible/
loading . . .
European vascular liver diseases network
Vascular liver diseases are a heterogeneous group of rare disorders characterized by an impaired vascular flow in the splanchnic and/or intrahepatic vasculature. They mainly include recent portal...
https://www.cost.eu/actions/CA23146/
8 months ago
0
1
2
📢📢 looking for a co-founder (CEO) for an early stage medtech startup‼️ Our goal: bring extracellular vesicles from the lab to the bedside of patients with chronic liver disease.🧪 Find the offer here:
www.lesdeeptech.fr/tandem/41693...
8 months ago
0
2
1
📢📢 Analysis of 249 patients with MASLD and of 2 rat models: ⚠️Liver endothelial cell (LSEC) capillarisation appears before MASH onset ❌LSEC capillarisation progresses with liver fibrosis and inflammation ✅Lanifibranor improves LSEC function
authors.elsevier.com/sd/article/S...
9 months ago
0
0
0
Tips for managing invasive procedures in patients with cirrhosis 🩸🩸: ➡️What limits of laboratory values❓ ➡️How to risk stratify procedures❓ ➡️When to stop and restart anticoagulants and antiplatelet agents❓ Find this and more there:
doi.org/10.3350/cmh....
9 months ago
0
0
0
📢📢Interested in vascular liver diseases❓ Check the opportunities for: ✅Short Term Scientific Mission 🧳 Deadline Feb 21 ✅Conference Grants Deadline March 14 ➡️ more details there
www.valdig.eu/cost-action-...
9 months ago
0
1
0
reposted by
Rui Castro
10 months ago
@rautoupe.bsky.social
provides an update on endothelium-platelet interactions in SLD: 🎯 LSEC capillarisation increases with liver fibrosis in MASLD 🎯 Aspirin improves MASLD 🎯 Likely by inhibiting platelet accumulation and/or platelet EV release
@easlnews.bsky.social
#SLDSummit
0
4
1
reposted by
LIVER-TRACK
10 months ago
➡️ Following by Marion Biquard's speech on the measurement of the EV proteins 🧬
@rautoupe.bsky.social
@ap-hp.bsky.social
@institutcurie.bsky.social
1
2
1
reposted by
LIVER-TRACK
10 months ago
🔬The proteomic aspect of the LIVER-TRACK project was presented by Prof. Laure Elkrief 🩺
@rautoupe.bsky.social
@cri1149.bsky.social
1
1
1
reposted by
LIVER-TRACK
10 months ago
🧪The Curie Core Tech team is an essential partner for the proteomics aspect of the RHU LIVER-TRACK project. We are very pleased with their contribution alongside us🙏
@institutcurie.bsky.social
@ap-hp.bsky.social
@rautoupe.bsky.social
1
1
1
reposted by
LIVER-TRACK
10 months ago
➡️Catlado Schietroma from Abbelight, a partner in the RHU LIVER-TRACK project,has presented the progress of their work in WP3 of LIVER-TRACK🧬🧬
@rautoupe.bsky.social
1
1
1
reposted by
LIVER-TRACK
10 months ago
🙏A big thank you to Prof. Cedric Laouenan🩺 for his insightful presentation during the Livertrack General Assembly! Your contribution was highly appreciated👌
#Livertrack
#GeneralAssembly
#Gratitude
@hopitalbichat.bsky.social
@rautoupe.bsky.social
@ap-hp.bsky.social
1
2
1
reposted by
LIVER-TRACK
10 months ago
▶️ A real pleasure to hear Professor Durand Zaleski discuss the medical-economic costs and what will be done in the RHU LIVER-TRACK project 💸💸 Looking forward to the upcoming developments!
#LiverTrack
#MedicalEconomics
#RHU
@ap-hp.bsky.social
@rautoupe.bsky.social
@hoteldieuparis.bsky.social
1
1
1
reposted by
LIVER-TRACK
10 months ago
🔝What a pleasure to welcome Professor Annalisa Berzigotti from the University of Bern🇨🇭 for a keynote lecture following our General Assembly. Thank you so much 👏
#Rhu
#Livertrack
#SABmeeting
@rautoupe.bsky.social
@ap-hp.bsky.social
0
1
1
reposted by
LIVER-TRACK
10 months ago
🎉 It’s the big day! 🎉 Today is our General Assembly & SAB. We look forward to meet everyone.
#livertrack
#SAB
#Generalassembly
#RHU
@hophenrimondor.bsky.social
@rautoupe.bsky.social
@institutcurie.bsky.social
@sorbonne-universite.fr
@upcite.bsky.social
@institutcurie.bsky.social
1
2
1
reposted by
LIVER-TRACK
10 months ago
🩺 Professor Rautou, the project coordinator, welcomed the partners to the meeting by giving an overview of the LIVER-TRACK project ▶️
@rautoupe.bsky.social
@ap-hp.bsky.social
@upcite.bsky.social
0
2
1
reposted by
LIVER-TRACK
10 months ago
🔙 A look back to the fantastic General Assembly of LIVER-TRACK! 🙌 A big thank you to all our partners for being there and to our experts for their valuable insights and availability. Your contributions made it a success! 💡🤝
#LiverTrack
#GeneralAssembly
@rautoupe.bsky.social
@ap-hp.bsky.social
0
1
1
reposted by
LIVER-TRACK
10 months ago
🚨 T-5 Days until our General Assembly & SAB! 🚨 We can’t wait to see you all and share the latest progress of our project. Exciting times ahead as we welcome our experts to join us and contribute to the discussion! 🔥 Stay tuned for more updates!
#LiverTrack
@rautoupe.bsky.social
@ap-hp.bsky.social
0
1
1
reposted by
LIVER-TRACK
11 months ago
🎉 The Livertrack team wishes you a very Happy New Year 2025! 🥳 May this year be filled with success, joy, and new opportunities. Here's to a fantastic year ahead! 🚀
#HappyNewYear
#2025
#Livertrack
@rautoupe.bsky.social
@inserm.bsky.social
@institutcurie.bsky.social
@ap-hp.bsky.social
0
2
1
reposted by
Annalisa Berzigotti
11 months ago
The second EASL Lancet commission coordinated by Tom Karlsen met in Geneva - we need to improve liver health in Europe and we worked to better understand how it can be done. Inspiring experience and great work in progress
@thelancet.bsky.social
@ec.europa.eu
@aleksanderkrag.bsky.social
1
6
1
Hepato-pulmonary syndrome (HPS) in 196 patients with PSVD: ▶️prevalence: 7% ▶️risk factors: telomere biology disorders & less preserved liver function ▶️outcome similar to PSVD patients w/o HPS when applying HPS MELD exception policy for transplantation
jhep-reports.eu/article/S258...
11 months ago
0
3
0
you reached the end!!
feeds!
log in